trying...
270963192016092620210108
1097-41804442016Apr19ImmunityImmunityBrain Endothelial- and Epithelial-Specific Interferon Receptor Chain 1 Drives Virus-Induced Sickness Behavior and Cognitive Impairment.901912901-1210.1016/j.immuni.2016.04.005S1074-7613(16)30110-8Sickness behavior and cognitive dysfunction occur frequently by unknown mechanisms in virus-infected individuals with malignancies treated with type I interferons (IFNs) and in patients with autoimmune disorders. We found that during sickness behavior, single-stranded RNA viruses, double-stranded RNA ligands, and IFNs shared pathways involving engagement of melanoma differentiation-associated protein 5 (MDA5), retinoic acid-inducible gene 1 (RIG-I), and mitochondrial antiviral signaling protein (MAVS), and subsequently induced IFN responses specifically in brain endothelia and epithelia of mice. Behavioral alterations were specifically dependent on brain endothelial and epithelial IFN receptor chain 1 (IFNAR). Using gene profiling, we identified that the endothelia-derived chemokine ligand CXCL10 mediated behavioral changes through impairment of synaptic plasticity. These results identified brain endothelial and epithelial cells as natural gatekeepers for virus-induced sickness behavior, demonstrated tissue specific IFNAR engagement, and established the CXCL10-CXCR3 axis as target for the treatment of behavioral changes during virus infection and type I IFN therapy.Copyright © 2016 Elsevier Inc. All rights reserved.BlankThomasTInstitute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany.DetjeClaudia NCNInstitute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Medical School Hannover, 30625 Hannover, Germany.SpießAlenaAInstitute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany.HagemeyerNoraNInstitute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany.BrendeckeStefanie MSMInstitute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany.WolfartJakobJOscar Langendorff Institute of Physiology, University of Rostock, 18057 Rostock, Germany.StaszewskiOriOInstitute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany.ZöllerTanjaTInstitute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany.PapageorgiouIsminiIInstitute of Physiology and Pathophysiology, University of Heidelberg, 69120 Heidelberg, Germany.SchneiderJustusJInstitute of Physiology and Pathophysiology, University of Heidelberg, 69120 Heidelberg, Germany.Paricio-MontesinosRicardoRInstitute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany.EiselUlrich L MULDepartment of Molecular Neurobiology, Groningen Institute of Evolutionary Life Sciences, University of Groningen, and Department of Psychiatry, University Medical Center Groningen, 9700 Groningen, The Netherlands.Manahan-VaughanDeniseDRuhr University Bochum, Medical Faculty, Department Neurophysiology, 44780 Bochum, Germany.JansenStephanSRuhr University Bochum, Medical Faculty, Department Neurophysiology, 44780 Bochum, Germany.LienenklausStefanSInstitute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Medical School Hannover, 30625 Hannover, Germany; Institute for Laboratory Animal Science, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.LuBaoBChildren's Hospital, Harvard Medical School, Boston, MA 02115, USA.ImaiYumikoYDepartment of Biological Informatics and Experimental Therapeutics, Akita University Graduate School of Medicine, Akita 010-8543, Japan.MüllerMarcusMDepartment of Neurology, Universitätsklinikum Bonn, 53105 Bonn, Germany.GoelzSusan ESEPortland, Oregon, 97201, USA.BakerDarren PDPBiogen Inc., Cambridge, MA 02142, USA.SchwaningerMarkusMInstitute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, 23538 Lübeck, Germany.KannOliverOInstitute of Physiology and Pathophysiology, University of Heidelberg, 69120 Heidelberg, Germany.HeikenwalderMathiasMInstitute of Virology, Technische Universität München/ Helmholtz-Zentrum München, 81756 München, Germany; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.KalinkeUlrichUInstitute for Experimental Infection Research, TWINCORE, Centre for Experimental and Clinical Infection Research, a joint venture between the Helmholtz Centre for Infection Research and the Medical School Hannover, 30625 Hannover, Germany.PrinzMarcoMInstitute of Neuropathology, University of Freiburg, 79106 Freiburg, Germany; BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany. Electronic address: marco.prinz@uniklinik-freiburg.de.engGEOGSE74063Journal ArticleResearch Support, Non-U.S. Gov't
United StatesImmunity94329181074-76130Adaptor Proteins, Signal Transducing0Chemokine CXCL100Cxcl10 protein, mouse0Cxcr3 protein, mouse0IPS-1 protein, mouse0Ifnar1 protein, mouse0Interferon Type I0RNA, Double-Stranded0Receptors, CXCR3156986-95-7Receptor, Interferon alpha-betaEC 3.6.1.-Ddx58 protein, mouseEC 3.6.1.-Ifih1 protein, mouseEC 3.6.4.13DEAD Box Protein 58EC 3.6.4.13DEAD-box RNA HelicasesEC 3.6.4.13Interferon-Induced Helicase, IFIH1IMImmunity. 2016 Apr 19;44(4):718-20. doi: 10.1016/j.immuni.2016.03.01027096312Adaptor Proteins, Signal TransducingmetabolismAnimalsBraincytologyimmunologyCell CommunicationimmunologyCells, CulturedChemokine CXCL10immunologyCognition DisordersgeneticspsychologyDEAD Box Protein 58DEAD-box RNA HelicasesmetabolismEndothelial CellsimmunologyEndotheliumcytologyimmunologyEpithelial CellsimmunologyEpitheliumimmunologyIllness BehaviorphysiologyInterferon Type Itherapeutic useInterferon-Induced Helicase, IFIH1MaleMiceRNA, Double-StrandedgeneticsReceptor, Interferon alpha-betageneticsimmunologyReceptors, CXCR3immunologySignal TransductionimmunologyVirus DiseasesimmunologyCXCL10CXCR3IFNIFNAR1IPS-1MAVSbehaviorbraindepressionendotheliaepitheliainfluenzaneuronssignal transductiontype I interferonvirus infection
201411320151019201615201642160201642160201692760ppublish2709631910.1016/j.immuni.2016.04.005S1074-7613(16)30110-8
trying2...
trying...
trying2...
Brain Endothelial- and Epithelial-Specific Interferon Receptor Chain 1 Drives Virus-Induced Sickness Behavior and Cognitive Impairment. | LitMetric

Sickness behavior and cognitive dysfunction occur frequently by unknown mechanisms in virus-infected individuals with malignancies treated with type I interferons (IFNs) and in patients with autoimmune disorders. We found that during sickness behavior, single-stranded RNA viruses, double-stranded RNA ligands, and IFNs shared pathways involving engagement of melanoma differentiation-associated protein 5 (MDA5), retinoic acid-inducible gene 1 (RIG-I), and mitochondrial antiviral signaling protein (MAVS), and subsequently induced IFN responses specifically in brain endothelia and epithelia of mice. Behavioral alterations were specifically dependent on brain endothelial and epithelial IFN receptor chain 1 (IFNAR). Using gene profiling, we identified that the endothelia-derived chemokine ligand CXCL10 mediated behavioral changes through impairment of synaptic plasticity. These results identified brain endothelial and epithelial cells as natural gatekeepers for virus-induced sickness behavior, demonstrated tissue specific IFNAR engagement, and established the CXCL10-CXCR3 axis as target for the treatment of behavioral changes during virus infection and type I IFN therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.immuni.2016.04.005DOI Listing

Publication Analysis

Top Keywords

sickness behavior
16
receptor chain
8
virus-induced sickness
8
behavior cognitive
8
brain endothelial
8
endothelial epithelial
8
behavioral changes
8
brain
4
brain endothelial-
4
endothelial- epithelial-specific
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!